Component

Sec-tRNA[Ser]Sec

The specialized transfer RNA carrying selenocysteine for UGA recoding.

6 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. A constrained Sec-tRNA supply can impair selenocysteine insertion at UGA in a transcript-dependent manner.

    Sec-tRNA[Ser]Sec → UGA recoding source_derived_draftsource_reported: Cell/biochemical mechanism; source-derived unverified synthesis.
    Experimental context and source evidence
    availability_state
    Selenium intake or availability becomes inadequate for the cellular context.
    experimental_scope
    Biochemical pathway and experimental shortage model; effects depend on transcript and tissue.
    limitations
    This is a conditional supply constraint, not a prediction that all selenoproteins fall equally. No validated plasma cutoff is assigned.
    trigger_kind
    nutrient_deficiency

    Selenium deficiency: a mechanism-first reference · lines 35–45

    Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    Sec-tRNA^[Ser]Sec ↓ eEFSec ribosome reaches UGA ↓ SECIS + SECISBP2/SBP2 machinery ↓ SELENOCYSTEINE INSERTED SerRS charging tRNA^[Ser]Sec with serine is an obligatory biosynthetic step, not a mistake. SEPHS2 supplies selenophosphate, while PSTK and SEPSECS convert the serine-charged tRNA into Sec-tRNA^[Ser]Sec. UGA recoding is intrinsically less straightforward than ordinary amino-acid insertion and its efficiency varies substantially by transcript and cellular context. It should not be treated as a universal 5–10% process across all selenoprotein mRNAs.

    Selenium deficiency: a mechanism-first reference · lines 783–790

    Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    selenium intake / availability ↓ │ ▼ central selenium metabolism and Sec-tRNA supply become constrained │ ├─ tRNA^[Ser]Sec modification can shift (including Um34 / FTSJ1 biology) ├─ SECIS-dependent UGA recoding changes ├─ selected transcripts can undergo stronger repression / NMD
    Complete structured claim and evidence
  2. Sec-tRNA enables translation of SELENOK.

    Sec-tRNA[Ser]Sec → SELENOK source_derived_draftsupplied_source_only
    Experimental context and source evidence
    cell_type
    · T cell
    evidence_scope
    Source-derived draft; primary-source verification required
    organism
    · Human

    Selenium in immune cells · lines 11–20

    Selenium immune-cell mechanism draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    # I. THE CLEANEST CHAIN — SELENOK → Ca²⁺ → NFAT → IL-2 This is the one to memorize. It's a direct, non-redox, molecule-by-molecule path from a selenium atom to a cytokine. ``` 1. Se → Sec-tRNA → SELENOK (ER membrane, single C-terminal Sec, tail in cytosol) 2. SELENOK binds ZDHHC6 (ER palmitoyl-S-acyltransferase, DHHC motif) → SELENOK is required as a COFACTOR to stabilize the palmitoyl-ZDHHC6 acyl-enzyme intermediate
    Complete structured claim and evidence

What acts on it

  1. When selenium availability falls, the Sec-tRNA supply can become constrained.

    Selenium → Sec-tRNA[Ser]Sec source_derived_draftsource_reported: Cell/biochemical mechanism; source-derived unverified synthesis.
    Experimental context and source evidence
    availability_state
    Selenium intake or availability becomes inadequate for the cellular context.
    experimental_scope
    Biochemical pathway and experimental shortage model; effects depend on transcript and tissue.
    limitations
    This is a conditional supply constraint, not a prediction that all selenoproteins fall equally. No validated plasma cutoff is assigned.
    trigger_kind
    nutrient_deficiency

    Selenium deficiency: a mechanism-first reference · lines 783–790

    Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    selenium intake / availability ↓ │ ▼ central selenium metabolism and Sec-tRNA supply become constrained │ ├─ tRNA^[Ser]Sec modification can shift (including Um34 / FTSJ1 biology) ├─ SECIS-dependent UGA recoding changes ├─ selected transcripts can undergo stronger repression / NMD
    Complete structured claim and evidence
  2. Pathogenic SEPSECS impairment can disrupt Sec-tRNA synthesis.

    SEPSECS / SepSecS → Sec-tRNA[Ser]Sec source_derived_draftsource_reported: Human genetic and biochemical evidence as summarized in the supplied source; unverified synthesis.
    Experimental context and source evidence
    availability_state
    Pathogenic SEPSECS impairment affecting Sec-tRNA synthesis.
    experimental_scope
    Rare human genetic disorders and the defined Sec-tRNA biosynthetic pathway.
    limitations
    This is not ordinary selenium dietary deficiency. SEPSECS being the SLA/LP autoantigen does not make autoimmune hepatitis a selenium-deficiency disease.
    trigger_kind
    machinery_impairment

    Selenium deficiency: a mechanism-first reference · lines 23–43

    Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    Selenocysteine (Sec) is unusual because it is synthesized on its own tRNA rather than existing as a large free amino-acid pool. There is no dedicated Sec-tRNA synthetase. Instead, two biosynthetic branches converge: Serine + tRNA^[Ser]Sec ↓ SerRS Ser-tRNA^[Ser]Sec ↓ PSTK PSer-tRNA^[Ser]Sec ────────────────────────┐ │ Selenide + ATP │ ↓ SEPHS2 │ selenophosphate ───────────────────────────┤ ↓ SEPSECS Sec-tRNA^[Ser]Sec ↓ eEFSec ribosome reaches UGA ↓ SECIS + SECISBP2/SBP2 machinery ↓ SELENOCYSTEINE INSERTED SerRS charging tRNA^[Ser]Sec with serine is an obligatory biosynthetic step, not a mistake. SEPHS2 supplies selenophosphate, while PSTK and SEPSECS convert the serine-charged tRNA into Sec-tRNA^[Ser]Sec.

    Selenium deficiency: a mechanism-first reference · lines 541–545

    Supplied selenium deficiency reference · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    SEPSECS Sec-tRNA synthesis defect Pontocerebellar hypoplasia spectrum
    Complete structured claim and evidence
  3. PLP-dependent SEPSECS converts phosphoseryl-tRNA Sec to Sec-tRNA through phosphate elimination and selenium donation from selenophosphate, not incorporation of intact selenophosphate.

    SEPSECS / SepSecS → Sec-tRNA[Ser]Sec source_derived_draftliterature_reviewed:direct_experimental
    Experimental context and source evidence
    cell_type
    Purified enzyme/tRNA
    experimental_model
    Human enzyme/tRNA crystallography and biochemical assays
    limitations
    Not a measurement of dietary intake effects.
    organism
    Homo sapiens

    Selenium: literature corrections and mechanism additions · lines 1154–1164

    Metabolic Ledger literature curation, 17 September 2026; primary papers linked individually · supports · Human enzyme/tRNA crystallography and biochemical assays · secondary_verified · secondary_verified

    ## sepsecs-chemistry SEPSECS uses selenium from the donor to finish the tRNA-bound amino acid. PLP-dependent SEPSECS converts phosphoseryl-tRNA Sec to Sec-tRNA through phosphate elimination and selenium donation from selenophosphate, not incorporation of intact selenophosphate. Organism: Homo sapiens Cell type: Purified enzyme/tRNA Experimental model: Human enzyme/tRNA crystallography and biochemical assays Limitations: Not a measurement of dietary intake effects. Primary reference: [The human SepSecS–tRNASec complex reveals mechanism of selenocysteine formation](https://pubmed.ncbi.nlm.nih.gov/19608919/)
    Complete structured claim and evidence
  4. Selenium availability supports the specialized Sec-tRNA pool.

    Selenium → Sec-tRNA[Ser]Sec source_derived_draftsupplied_source_only
    Experimental context and source evidence
    cell_type
    · T cell
    evidence_scope
    Source-derived draft; primary-source verification required
    organism
    · Human

    Selenium in immune cells · lines 11–20

    Selenium immune-cell mechanism draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    # I. THE CLEANEST CHAIN — SELENOK → Ca²⁺ → NFAT → IL-2 This is the one to memorize. It's a direct, non-redox, molecule-by-molecule path from a selenium atom to a cytokine. ``` 1. Se → Sec-tRNA → SELENOK (ER membrane, single C-terminal Sec, tail in cytosol) 2. SELENOK binds ZDHHC6 (ER palmitoyl-S-acyltransferase, DHHC motif) → SELENOK is required as a COFACTOR to stabilize the palmitoyl-ZDHHC6 acyl-enzyme intermediate
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards